Pharmacogenomics

Genotype-to-Drug Associations

Genotype-to-drug associations play a vital role in personalized medicine, enabling healthcare providers to tailor treatments based on an individual’s genetic makeup. In this section, you can explore the relationships between specific genetic variants and their […]

Pharmacogenomics

Drug-to-Genotype Associations (FDA List)

The FDA recognizes the importance of understanding drug-to-genotype associations in order to optimize treatment and minimize adverse effects. In this section, you can access a comprehensive list of FDA-recognized associations, which can provide valuable insights […]

Pharmacogenomics

Drug-to-Genotype Associations (All)

A deeper understanding of the interactions between genetics and drug response is critical for advancing personalized medicine. In this section, you can explore our extensive database of drug-to-genotype associations, including those not recognized by the […]

Cancer Research

Tumor Mutation Load Assay 

At Genet, we offer the “Oncomine Tumor Mutation Load Assay,” a cutting-edge service designed to identify cancer driver variants and evaluate tumor mutational burden (TMB), a promising immuno-oncology biomarker, utilizing next-generation sequencing technology. Immune checkpoint […]

Cancer Research

Solid Tumor

An abnormal mass of tissue that usually does not contain cysts or liquid areas. […]

Cancer Research

Myeloid disorders

Myeloid disorders comprise a diverse group of hematologic conditions, including various forms of leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. At Genet, we are committed to advancing clinical research in the field of myeloid disorder genetics. […]

Cancer Research

Lymphoma

Lymphoma is a group of blood cancers that originate in the lymphatic system and primarily affect the lymphocytes, a type of white blood cell. The two main categories of lymphoma are Hodgkin lymphoma and non-Hodgkin […]

Cancer Research

Liver Cancer

Liver Cancer Research Liver cancer is a malignant condition that originates in the liver cells, with hepatocellular carcinoma being the most common form. At Genet, we are dedicated to advancing clinical research in the field […]

Cancer Research

HRR Pathway

The following targets are included in the Oncomine™ HRR Pathway Predesigned Panel: